Get informed when a big investor buys or sells
+ Follow28.42
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
The latest PEG ratio for DMPWW is 28.42. That is above the Materials sector average of 5.19. Investors often review this figure alongside DelMar Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.
Against Materials companies, DMPWW currently prints 28.42 for PEG ratio, while the sector average sits near 5.19. That is roughly 447.7% above the sector mean. Large gaps often invite a closer look at DelMar Pharmaceuticals's growth, margins, and balance sheet.
A PEG ratio of 28.42 for DelMar Pharmaceuticals is not 'good' or 'bad' on its own. Compare it with the peer average (5.19) and with DMPWW's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting DMPWW's PEG ratio (28.42), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack DelMar Pharmaceuticals's PEG ratio against similar Materials names. You can also browse sector and industry screens on Stockcircle for a broader set of Materials companies and their key multiples and fundamentals.